ARCHIVES

In Brief: FDA approves Three-Hour Taxol Infusion; Foti Elected President Of NCCR; Luce Retires

This article is from The Cancer Letter archive.

Vol. 20 No. 34 | September 9, 1994

Download PDF Visit The Full Archive

Related Articles

Symposium Planned On Hyperthermia

April 23, 1976

Conference Level For NCI Is 5.4% Over FY 1990

November 2, 1990

Klausner Reaffirms NCI’s “No. 1 Priority” Is Funding investigator-Initiated Research

September 13, 1996

NCI Offers 200 Cell Lines to Scientist

May 6, 1983

In Brief: President Clinton Appoints Six New Members To The National Cancer Advisory Board

December 11, 1998

NIH On R29 Phase-Out; Grant Review Appeals Process Changed

January 23, 1998